Proline-Hinged α-Helical Peptides Sensitize Gram-Positive Antibiotics, Expanding Their Physicochemical Properties to Be Used as Gram-Negative Antibiotics.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
21 Dec 2023
Historique:
pubmed: 21 12 2023
medline: 21 12 2023
entrez: 21 12 2023
Statut: aheadofprint

Résumé

The outer membrane (OM) of Gram-negative bacteria is the most difficult obstacle for small-molecule antibiotics to reach their targets in the cytosol. The molecular features of Gram-negative antibiotics required for passing through the OM are that they should be positively charged rather than neutral, flat rather than globular, less flexible, or more increased amphiphilic moment. Because of these specific molecular characteristics, developing Gram-negative antibiotics is difficult. We focused on sensitizer peptides to facilitate the passage of hydrophobic Gram-positive antibiotics through the OM. We explored ways of improving the sensitizing ability of proline-hinged α-helical peptides by adjusting their length, hydrophobicity, and N-terminal groups. A novel peptide, 1403, improves the potentiation of rifampicin

Identifiants

pubmed: 38124427
doi: 10.1021/acs.jmedchem.3c01473
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Yoonhwa Choi (Y)

Department of Chemistry & Education, Seoul National University, Seoul 08826, Republic of Korea.
CAMP Therapeutics, Seoul 08826, Republic of Korea.

Hyeong Woon Choe (HW)

Department of Chemistry & Education, Seoul National University, Seoul 08826, Republic of Korea.

Minsoo Kook (M)

Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Seolah Choo (S)

Department of Chemistry & Education, Seoul National University, Seoul 08826, Republic of Korea.

Tae Woo Park (TW)

Department of Chemistry & Education, Seoul National University, Seoul 08826, Republic of Korea.

Soeun Bae (S)

Department of Chemistry & Education, Seoul National University, Seoul 08826, Republic of Korea.

Heeseung Kim (H)

Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Jihye Yang (J)

Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Woo-Seong Jeong (WS)

Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 28116, Republic of Korea.

Jiyoung Yu (J)

Asan Medical Center, Seoul 05505, Republic of Korea.

Kyeong-Ryoon Lee (KR)

Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju 28116, Republic of Korea.

Yang Soo Kim (YS)

Department of Infectious Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.

Jaehoon Yu (J)

Department of Chemistry & Education, Seoul National University, Seoul 08826, Republic of Korea.
CAMP Therapeutics, Seoul 08826, Republic of Korea.

Classifications MeSH